All Stories

  1. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking
  2. Docking of anti-HIV-1 oxoquinoline-acylhydrazone derivatives as potential HSV-1 DNA polymerase inhibitors
  3. Molecular Docking Studies of Marine Diterpenes as Inhibitors of Wild-Type and Mutants HIV-1 Reverse Transcriptase
  4. Hologram quantitative structure–activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide HIV-1 integrase inhibitors
  5. Structural model of haptoglobin and its complex with the anticoagulant ecotin variants: structure–activity relationship study and analysis of interactions
  6. Molecular Modeling of a Phenyl‐Amidine Class of NMDA Receptor Antagonists and the Rational Design of New Triazolyl‐Amidine Derivatives
  7. Molecular Modeling Studies of the Structural, Electronic, and UV Absorption Properties of Benzophenone Derivatives
  8. Hologram QSAR Models of 4-[(Diethylamino)methyl]-phenol Inhibitors of Acetyl/Butyrylcholinesterase Enzymes as Potential Anti-Alzheimer Agents
  9. Molecular Dynamics Simulations of Peptide Inhibitors Complexed With Trypanosoma cruzi Trypanothione Reductase
  10. Residue-Ligand Interaction Energy (ReLIE) on a Receptor-Dependent 3D-QSAR Analysis of S- and NH-DABOs as Non-Nucleoside Reverse Transcriptase Inhibitors
  11. Application of 4D-QSAR Studies to a Series of Raloxifene Analogs and Design of Potential Selective Estrogen Receptor Modulators
  12. CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase
  13. The role of helices 5 and 6 on the human β1-adrenoceptor activation mechanism
  14. Receptor‐Dependent 4D‐QSAR Analysis of Peptidemimetic Inhibitors of Trypanosoma cruzi Trypanothione Reductase with Receptor‐Based Alignment
  15. Molecular modeling studies of 1,4-dihydro-4-oxoquinoline ribonucleosides with anti-HSV-1 activity
  16. Dynamical behaviour of the human β1-adrenoceptor under agonist binding
  17. Kinetic resolution of (±)-1,2-O-isopropylidene-3,6-di-O-benzyl-myo-inositol by lipases: An experimental and theoretical study on the reaction of a key precursor of chiral inositols
  18. Trypanosoma cruzi: Insights into naphthoquinone effects on growth and proteinase activity
  19. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE)
  20. Conformational analysis of a quinolonic ribonucleoside with anti-HSV-1 activity
  21. Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer’s disease
  22. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes
  23. Molecular docking of a series of peptidomimetics in the trypanothione binding site of T. cruzi Trypanothione Reductase
  24. Leishmania amazonensis Growth Inhibitors: Biological and Theoretical Features of Sulfonamide 4-Methoxychalcone Derivatives
  25. Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid benzylidene-carbohydrazide series
  26. ChemInform Abstract: 3D‐QSAR CoMFA of a Series of DABO Derivatives as HIV‐1 Reverse Transcriptase Non‐Nucleoside Inhibitors.
  27. 3D-QSAR CoMFA of a Series of DABO Derivatives as HIV-1 Reverse Transcriptase Non-Nucleoside Inhibitors
  28. Deamination process in the formation of a copper(II) complex with glutamic acid and a new ligand derived from guanidinoacetic acid: Synthesis, characterization, and molecular modeling studies
  29. Solid-state 13C NMR and molecular modeling studies of acetyl aleuritolic acid obtained from Croton cajucara Benth
  30. SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series
  31. Molecular dynamics simulations of a nucleoside analogue of 1,4-dihydro-4-oxoquinoline-3-carboxylic acid synthesized as a potential antiviral agent: Conformational studies in vacuum and in water
  32. Structure–function inferences based on molecular modeling, sequence-based methods and biological data analysis of snake venom lectins
  33. Free-energy force-field three-dimensional quantitative structure–activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors
  34. Construction of 4D-QSAR Models for Use in the Design of Novel p38-MAPK Inhibitors
  35. 4D-QSAR Models of HOE/BAY-793 Analogues as HIV-1 Protease Inhibitors
  36. Theoretical studies of the asymmetric alkylation reaction on chiral enamines
  37. LIV-3D-QSAR model for estrogen receptor ligands
  38. LIV-3D-QSAR models for PGI2 receptor ligands using multiple conformations
  39. Local intersection volume (LIV) descriptors: 3D-QSAR models for PGI2 receptor ligands
  40. Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands
  41. Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism
  42. Modelagem Molecular: Uma Ferramenta para o Planejamento Racional de Fármacos em Química Medicinal
  43. Design of new potential 5-lipoxygenase inhibitors, dual thromboxane synthase inhibitors, and thromboxane a2 receptor antagonists byAM1